Molecular mechanisms driving HCC development in mouse model of hepatitis-associated cancer

Number of publications: 4
Israeli Partner: Y. Ben-Neriah, Hebrew Univ.
German Partner: P. Angel, DKFZ

Publications

Publication
Publication
Gebhardt, C., Riehl, A., Durchdewald, M., Nemeth, J., Furstenberger, G., Muller-Decker, K., Enk, A., Arnold, B., Bierhaus, A., Nawroth, P. P., Hess, J., Angel, P.

RAGE signaling sustains inflammation and promotes tumor development 205 (2), J Exp Med, 275-85, 2008

Nemeth, J., Stein, I., Haag, D., Riehl, A., Longerich, T., Horwitz, E., Breuhahn, K., Gebhardt, C., Schirmacher, P., Hahn, M., Ben-Neriah, Y., Pikarsky, E., Angel, P., Hess, J.

S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis 50 (4), Hepatology, 1251-62, 2009

Riehl, A., Bauer, T., Brors, B., Busch, H., Mark, R., Nemeth, J., Gebhardt, C., Bierhaus, A., Nawroth, P., Eils, R., Konig, R., Angel, P., Hess, J.

Identification of the Rage-dependent gene regulatory network in a mouse model of skin inflammation 11, BMC Genomics, 537, 2010

Riehl, A., Nemeth, J., Angel, P., Hess, J.

The receptor RAGE: Bridging inflammation and cancer 7, Cell Commun Signal, 12, 2009

to top